Southern Star Research Wins Best CRO in Australia at the Asia-Pacific Biopharma Excellence Awards 2026

Southern Star Research Wins Best CRO in Australia at the Asia-Pacific Biopharma Excellence Awards 2026  

Celebrating Leadership in Clinical Research and Operational Excellence  

Singapore, 13 March 2026 – Southern Star Research has been awarded the Best Contract Research Organization (CRO) in Australia at the Asia-Pacific Biopharma Excellence Awards 2026, held on 11 March at the Sands Expo & Convention Centre in Singapore.  

A total of 92 awards were presented, recognising outstanding achievements in areas such as bioprocessing innovation, biologics manufacturing, supply chain excellence, and emerging technologies that are advancing the industry.  

This recognition further reinforces Southern Star Research’s position as a trusted CRO partner across Australia and the Asia-Pacific region, supporting biotech, pharmaceutical, and medical device companies with high-quality clinical trial delivery, strong regulatory expertise, and patient-focused operational excellence.  

“Winning this award is a strong validation of the work we’re doing,” said Mr Lloyd Prescott, CEO, Southern Star Research. “As a peer-voted recognition, it shows that the industry is paying attention to the value we bring as an early-phase specialist CRO supporting innovative biotech companies.”  

“This recognition comes at an important time for us as we invest in Expecto, a CRO in Asia,” said Mr Lloyd Prescott, CEO, Southern Star Research. “Through this investment, we are expanding our clinical operations footprint across the region and strengthening our ability to support biotech partners as their programmes progress.”  

As a full-service contract research organisation, Southern Star Research supports companies in simplifying and accelerating the clinical trial process. The company provides specialised expertise across medical writing, clinical monitoring, project management, biostatistics, data management, and quality assurance, enabling its partners to conduct high-quality studies and navigate complex clinical development programmes.  

With global capabilities and strong regional expertise, Southern Star Research supports multi-regional clinical trials, acting as a trusted advisor to guide sponsors through regulatory pathways while helping accelerate study outcomes.  

Watch the exclusive winner’s interview featuring Mr Lloyd Prescott, CEO, Southern Star Research, who accepted the award on behalf of the company, sharing what this recognition means for their team and how they continue to support biopharma companies in advancing clinical research across Australia and the wider Asia-Pacific region.: https://www.imapac.com/news-updates/abea2026-exclusive-interview-with-mr-lloyd-prescott-ceo-southern-star-research  
 

About Southern Star Research  

Southern Star Research is a full-service contract research organisation (CRO) supporting biotech, pharmaceutical, and medical device companies by simplifying and accelerating the clinical trial process.  

With a team of global experts, the company delivers high-quality services across medical writing, clinical monitoring, project management, biostatistics, data management, and quality assurance, tailored to meet the unique needs of each study.  

Through its international reach and strong local expertise, Southern Star Research enables multi-regional clinical trials, acting as a trusted advisor to guide sponsors through complex development pathways and accelerate successful study outcomes.  

About IMAPAC  

IMAPAC is a global market intelligence and business networking company specialising in life sciences, biopharmaceutical manufacturing, clinical research, and healthcare innovation. Through industry conferences, executive forums, and research-driven initiatives, IMAPAC connects senior leaders across the biopharmaceutical ecosystem to drive collaboration, innovation, and knowledge exchange.  

IMAPAC organises leading industry platforms across Asia, Europe, and North America, bringing together stakeholders from biopharma companies, contract service providers, regulators, and technology innovators to address the evolving challenges shaping the future of life sciences.  

About the Asia-Pacific Biopharma Excellence Awards  

The Asia-Pacific Biopharma Excellence Awards (ABEA) recognise outstanding organisations, technologies, and leaders driving innovation and excellence across the bioprocessing and biopharmaceutical manufacturing landscape in the Asia-Pacific region.  

Presented annually by IMAPAC, the awards celebrate achievements across categories including biologics development, manufacturing, outsourcing, digitalisation, and operational excellence, recognising organisations advancing the development of next-generation therapies.  

‍